If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.42
Bid: 2.38
Ask: 2.46
Change: -0.01 (-0.41%)
Spread: 0.08 (3.361%)
Open: 2.43
High: 0.00
Low: 0.00
Prev. Close: 2.43
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer Update

17 Jun 2021 09:52

RNS Number : 2433C
Globalworth Real Estate Inv Ltd
17 June 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

17 June 2021

Globalworth Real Estate Investments Limited ("Globalworth" or the "Company")

Offer Update

 

Globalworth notes that yesterday was the second closing date of the unilateral cash offer for the Company (the "Offer") by CPI Property Group S.A. ("CPI") and Aroundtown SA ("Aroundtown" and, together with CPI, the "Consortium") and that the Consortium has today extended the Offer again until 30 June 2021.

On 26 April 2021, a committee of the Globalworth board comprising independent directors (the "Independent Committee") announced that the Offer significantly undervalues the Company, its assets and its prospects. Further, the Independent Committee gave its views on the Offer in the response circular published by the Company on 26 May 2021 (the "Response Circular").

The Independent Committee notes that the Consortium has only received acceptances in respect of a total of 671,687 Globalworth Shares, representing approximately 0.30 per cent. of Globalworth's issued share capital.

The Independent Committee continues to advise Globalworth shareholders to take no action in relation to the Offer.

As stated in the Response Circular, the letter sent by the Independent Committee to the Consortium on 21 May 2021 and in the announcement on 3 June 2021, the Independent Committee remains willing to discuss with the Consortium alternative transactions to the Offer that may deliver greater value to all Globalworth Shareholders and continues to seek clarity in respect of the Consortium's anticipated plans for Globalworth.

 

Terms used but not defined in this announcement shall have the meanings given to them in the Response Circular.

 

Enquiries:

 

Globalworth

Via advisers

Geoff Miller, Chair of the Board

J.P. Morgan Cazenove (Financial Adviser)

Tel: +44 20 7742 4000

Massimo Saletti / Leon Li

Dwayne Lysaght / Jonty Edwards

Panmure Gordon (Rule 3 Adviser, Nominated Adviser and Joint Broker)

Tel: +44 20 7886 2500

Dominic Morley / Alina Vaskina

 

Important notices

This announcement is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for or sell or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction. The release, publication or distribution of this announcement in whole or in part in, into or from certain jurisdictions may be restricted by law and therefore persons in such jurisdictions should inform themselves about and observe such restrictions.

The person responsible for arranging for the release of this announcement on behalf of the Company is Nicola Marrin, Company Secretary.

Disclaimers

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Globalworth and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Globalworth for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to any matter referred to herein.

Panmure Gordon (UK) Limited ("Panmure Gordon") which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for Globalworth and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this document and will not be responsible to anyone other than Globalworth for providing the protections afforded to clients of Panmure Gordon or its affiliates, nor for providing advice in relation to any matter referred to herein.

Rule 26.1 Disclosure

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at www.globalworth.com, by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPDKOBQFBKKCAD
Date   Source Headline
29th May 20209:30 amRNSNotice of AGM and Availability of Annual Report
28th May 20205:00 pmRNSChange of Registered Office
28th May 20204:15 pmRNSBoard Changes
18th May 20207:00 amRNSS&P and Fitch investment grade ratings maintained
15th May 20207:00 amRNSPurchase of own shares and TVR
14th May 20207:00 amRNSPurchase of own shares and TVR
11th May 202010:10 amRNSPurchase of own shares and TVR
5th May 20209:56 amRNSSatisfaction of employee share awards and TVR
28th Apr 20204:32 pmRNSMoody’s investment grade credit rating maintained
27th Apr 20204:41 pmRNSSecond Price Monitoring Extn
27th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSPurchase of own shares and TVR
23rd Apr 20203:30 pmRNSBoard Changes
23rd Apr 20207:00 amRNSUpdate on Covid-19
21st Apr 20204:40 pmRNSSecond Price Monitoring Extn
21st Apr 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSDirectorate Change
26th Mar 202012:28 pmRNSPosting of Annual Report and Notice of AGM
16th Mar 20202:31 pmRNSBoard Changes and COVID-19 statement
16th Mar 20201:48 pmRNSHolding(s) in Company
6th Mar 202012:00 pmRNSCondensed Unaudited Results to 31 Dec 2019
26th Feb 20206:16 pmRNSRemuneration policy, Treasury shares transfer, TVR
6th Feb 20209:36 amRNSHolding(s) in Company
5th Feb 202010:44 amRNSHolding(s) in Company
4th Feb 20207:15 amRNSHolding(s) in Company
3rd Feb 20201:25 pmRNSDirector/PDMR Shareholding
3rd Feb 202012:25 pmRNSDirector/PDMR Shareholding
3rd Feb 20208:01 amRNSHolding(s) in Company
3rd Feb 20207:30 amRNSSale by Ioannis Papalekas of Remaining Stake
27th Jan 202010:45 amRNSHolding(s) in Company
20th Jan 20202:32 pmRNSDirector/PDMR Shareholding
16th Jan 202012:05 pmRNSSecond Interim Dividend Payment
20th Dec 20197:00 amRNSFurther Acquisition in Poland
6th Dec 20194:30 pmRNSDirector/PDMR Shareholding
3rd Dec 20197:00 amRNSTransfer of shares and Director/PDMR Shareholdings
22nd Nov 20197:00 amRNSPurchase of own shares and TVR
4th Nov 20197:00 amRNSAcquisitions in Poland
1st Nov 20197:00 amRNSNew EUR 200m unsecured revolving credit facility
29th Oct 20197:00 amRNSInaugural Sustainable Development Report
16th Oct 20197:00 amRNSHolding(s) in Company
15th Oct 20191:10 pmRNSHolding(s) in Company
15th Oct 201912:30 pmRNSHolding(s) in Company
11th Oct 20197:00 amRNSResult of Placing
10th Oct 20197:00 amRNSProposed Placing
1st Oct 20197:00 amRNSIntention to Raise Additional Equity
27th Sep 20197:00 amRNSUpdate on Poland
19th Sep 20197:00 amRNSInterim Results for the six months to 30 June 2019
30th Aug 20197:00 amRNSNotice of Results & Preliminary H1 Financials
25th Jul 20197:00 amRNSHolding(s) in Company
25th Jul 20197:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.